ULBI logo

Ultralife Corporation (ULBI)

$5.75

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on ULBI

Market cap

$95731445

EPS

0.1

P/E ratio

57.7

Price to sales

0.52

Dividend yield

--

Beta

0.875761

Price on ULBI

Previous close

$5.77

Today's open

$5.75

Day's range

$5.50 - $5.80

52 week range

$4.07 - $9.52

Profile about ULBI

CEO

Michael E. Manna

Employees

671

Headquarters

Newark, NY

Exchange

NASDAQ Global Market

Shares outstanding

16648947

Issue type

Common Stock

ULBI industries and sectors

Industrials

Industrial Goods

News on ULBI

Ultralife Corporation (ULBI) Q3 2025 Earnings Call Transcript

Ultralife Corporation ( ULBI ) Q3 2025 Earnings Call November 18, 2025 8:30 AM EST Company Participants Michael Manna - President, CEO & Director Philip A. Fain - CFO, Treasurer & Corporate Secretary Conference Call Participants Jody Burfening - Lippert/Heilshorn & Associates, Inc. Presentation Operator Good day, and thank you for standing by.

news source

Seeking Alpha • Nov 18, 2025

news preview

Ultralife Corporation Reports Third Quarter Results

NEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results:

news source

GlobeNewsWire • Nov 18, 2025

news preview

Ultralife Corporation to Report Third Quarter Results on November 18, 2025

NEWARK, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, November 18, 2025.

news source

GlobeNewsWire • Nov 13, 2025

news preview

Ultralife Corporation Files Form 12b-25 Notification of Late Filing

NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Form 10-Q for the third quarter ended September 30, 2025.

news source

GlobeNewsWire • Nov 7, 2025

news preview

Ultralife Corporation Receives Award for Its BA-5390 Military Batteries from U.S. Defense Logistics Agency

NEWARK, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received an award valued at approximately $5.2 million from the U.S. Government's Defense Logistics Agency (“DLA”) for its lithium manganese dioxide, non-rechargeable BA-5390 military batteries. The majority of the shipments are scheduled throughout 2026 with completion in early 2027.

news source

GlobeNewsWire • Sep 4, 2025

news preview

Ultralife Corporation (ULBI) Q2 2025 Earnings Call Transcript

Ultralife Corporation (NASDAQ:ULBI ) Q2 2025 Earnings Conference Call August 7, 2025 12:00 PM ET Company Participants Michael E. Manna - President, CEO & Director Philip A.

news source

Seeking Alpha • Aug 9, 2025

news preview

Ultralife (ULBI) Q2 Revenue Rises 13%

Ultralife (ULBI -17.03%), a specialty battery and communications systems manufacturer, reported its second quarter 2025 earnings on August 7, 2025, covering the period ended June 30. The report showed headline revenue (GAAP) grew 13.0% to $48.6 million, driven by the Electrochem acquisition.

news source

The Motley Fool • Aug 8, 2025

news preview

Ultralife Corporation to Report Second Quarter Results on August 7, 2025

NEWARK, N.Y., July 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2025 before the market opens on Thursday, August 7, 2025.

news source

GlobeNewsWire • Jul 29, 2025

news preview

Ultralife Loses Place On Index, But Is Rebounding Robustly

Ultralife was removed from the FTSE Russell 3000 Microcap Index due to a share price slump, but fundamentals remain strong, and recovery is underway. Recent earnings show robust revenue and EPS growth, boosted by the Electrochem acquisition and improved productivity, supporting a bullish outlook. The valuation remains attractive, with forecasted EPS growth and a one-year price target of $14.12, representing a significant upside from current levels.

news source

Seeking Alpha • Jul 1, 2025

news preview

Ultralife: Recharging Growth With Smart Acquisitions

Ultralife's revenue has been volatile in the past decade or so, but its recent comeback seems to have more legroom to grow. Through a series of recent acquisitions, the company has diversified its revenue dependence on government contracts and obtained access to a more domestic and overseas customer base. Key financial metrics demonstrate strong cash flow and organic integration of its acquisitions, supporting a positive outlook.

news source

Seeking Alpha • Jun 30, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Ultralife Corporation

Open an M1 investment account to buy and sell Ultralife Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in ULBI on M1